How do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?

Topics: Head and Neck Cancers • Radiation Oncology • Pediatric Oncology • Medical Oncology • Supportive Care • Mucositis • Probiotics

In light of the 4/2024 JCO publication by Peng et al., PMID 38215354

Answer from: Radiation Oncologist at Academic Institution

This is a very interesting study and I am excited to see continued studies into symptom mitigation for definitive chemoRT. I currently offer Ssk12 to my patients undergoing H+N RT (definitive or adjuvant). I see little potential downside as it is a relatively inexpensive intervention and they repor...

Comments

Radiation Oncologist at Radiation Oncologists PC
The recent data on bacterial decolonization to red...

Related Questions